CompanyGraph
4DMedical Limited
4DX · ASX · Australia
Price data from its 4DX listing on CXA
4dmedical.comFinancials as of FY2025
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- ScaleRevenue is $5.04M, lower than 95% of all stocks globally
- PositionOperating margin is -736.4%, lower than 95% of its Medical Devices peers (median 8.5%)
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.47BAUD1.76B · vs all stocks (USD)
Revenue (TTM)
7.06MAUD5.04M · vs all stocks (USD)
Profit Margin
0.00%vs Medical Devices peers
Beta
1.95xvs all stocks
52-Week Change
174.91%vs all stocks
Market Capitalization
2.47BAUD1.76B · vs all stocks (USD)
Enterprise Value
2.31BAUD1.65B · vs all stocks (USD)
Forward P/E
-221.03xvs Medical Devices peers
Price to Book (MRQ)
15.12xvs Medical Devices peers
Enterprise to Revenue
326.94xvs Medical Devices peers
Enterprise to EBITDA
-41.84xvs Medical Devices peers
Profit Margin
0.00%vs Medical Devices peers
Operating Margin
-736.38%vs Medical Devices peers
Return on Assets (TTM)
-15.62%vs Medical Devices peers
Return on Equity (TTM)
-174.43%vs Medical Devices peers
Revenue (TTM)
7.06MAUD5.04M · vs all stocks (USD)
Revenue per Share (TTM)
0.0120AUDUpdated Sep 21, 2026Quarterly Revenue Growth
42.30%vs Medical Devices peers
Gross Profit (TTM)
6.62MAUD4.72M · vs all stocks (USD)
EBITDA (TTM)
-55.18MAUD-39.37M · vs all stocks (USD)
Net Income (TTM)
-204.44MAUD-145.85M · vs all stocks (USD)
Operating Cash Flow (TTM)
-31.27MAUD-22.31M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-136.05MAUD-97.06M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.00AUDUpdated Sep 21, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Medical Devices peers
Revenue
5.78MAUDFY2025 · Jun 30, 2025Cost of Goods Sold
464.43KAUDFY2025 · Jun 30, 2025Gross Profit
5.31MAUDFY2025 · Jun 30, 2025Operating Income
-47.57MAUD-33.94M · vs all stocks (USD)
Pre-tax Income
-30.16MAUDFY2025 · Jun 30, 2025Income Tax Expense
-87.12KAUDFY2025 · Jun 30, 2025Net Income
-30.07MAUDFY2025 · Jun 30, 2025EBIT
-30.15MAUDFY2025 · Jun 30, 2025EBITDA (Income Statement)
-24.83MAUDFY2025 · Jun 30, 2025Research & Development
852.35KAUDFY2025 · Jun 30, 2025Selling, General & Administrative
34.80MAUDFY2025 · Jun 30, 2025Other Operating Expenses
11.91MAUDFY2025 · Jun 30, 2025Non-operating Interest Income
335.42KAUDFY2025 · Jun 30, 2025Non-operating Interest Expense
8.66KAUDFY2025 · Jun 30, 2025EPS (Basic)
-0.1400AUDFY2025 · Jun 30, 2025EPS (Diluted)
-0.1400AUDFY2025 · Jun 30, 2025Basic Shares Outstanding
214.78MSharesFY2025 · Jun 30, 2025Diluted Shares Outstanding
214.78MSharesFY2025 · Jun 30, 2025Cash & Cash Equivalents (End of Period)
6.88MAUDFY2025 · Jun 30, 2025Interest Paid
255.07KAUDFY2025 · Jun 30, 2025Capital Expenditures
-62.96KAUDFY2025 · Jun 30, 2025Net Intangibles (CF)
-197.43KAUDFY2025 · Jun 30, 2025Net Acquisitions
-297.38KAUDFY2025 · Jun 30, 2025Other Investing Activity
-1.06MAUDFY2025 · Jun 30, 2025Net Investing Cash Flow
-1.42MAUDFY2025 · Jun 30, 2025Common Stock Repurchase
-1.36MAUDFY2025 · Jun 30, 2025Other Financing Charges
-972.57KAUDFY2025 · Jun 30, 2025Net Financing Cash Flow
12.37MAUDFY2025 · Jun 30, 2025Shares Outstanding
465.54MSharesUpdated Sep 21, 2026% Held by Insiders
16.59%vs all stocks
% Held by Institutions
23.77%vs all stocks
Total Cash (MRQ)
277.95MAUD198.30M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.4650AUDUpdated Sep 21, 2026Total Debt (MRQ)
11.17MAUD7.97M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0656xvs Medical Devices peers
Current Ratio (MRQ)
30.79xvs Medical Devices peers
Book Value per Share (MRQ)
0.2850AUDUpdated Sep 21, 2026Total Assets
94.81MAUD67.64M · vs all stocks (USD)
Total Current Assets
17.06MAUDFY2025 · Jun 30, 2025Total Liabilities
30.58MAUDFY2025 · Jun 30, 2025Total Non-current Assets
77.75MAUDFY2025 · Jun 30, 2025Total Non-current Liabilities
11.32MAUDFY2025 · Jun 30, 2025Total Current Liabilities
19.25MAUDFY2025 · Jun 30, 2025Cash
6.88MAUDFY2025 · Jun 30, 2025Cash & Cash Equivalents
6.88MAUDFY2025 · Jun 30, 2025Accounts Receivable
1.19MAUDFY2025 · Jun 30, 2025Inventory
919.63KAUDFY2025 · Jun 30, 2025Accounts Payable
1.87MAUDFY2025 · Jun 30, 2025Short-term Debt
1.09MAUDFY2025 · Jun 30, 2025Deferred Revenue
799.18KAUDFY2025 · Jun 30, 2025Other Current Liabilities
11.25MAUDFY2025 · Jun 30, 2025Long-term Debt
3.22MAUDFY2025 · Jun 30, 2025Other Non-current Liabilities
154.77KAUDFY2025 · Jun 30, 2025Common Stock (Book)
239.97MAUDFY2025 · Jun 30, 2025Retained Earnings
-182.11MAUDFY2025 · Jun 30, 2025Total Shareholders' Equity
64.24MAUD45.83M · vs all stocks (USD)
52-Week Low
1.40AUDUpdated Sep 21, 202652-Week High
7.55AUDUpdated Sep 21, 202652-Week Change
174.91%vs all stocks
Beta
1.95xvs all stocks
50-Day MA
3.70AUDUpdated Sep 21, 2026200-Day MA
4.06AUDUpdated Sep 21, 2026Avg 10-Day Volume
4.14MSharesUpdated Sep 21, 2026Avg 30-Day Volume
4.12MSharesUpdated Sep 21, 2026Diluted EPS (TTM)
-0.3400AUDUpdated Sep 21, 2026Other Income / Expense
17.34MAUDFY2025 · Jun 30, 2025Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is -736.4%, lower than 95% of its Medical Devices peers (median 8.5%)Significant
Operating margin: -7.36Industry median: 0.08Industry P5: -1.00Peers compared: 60.00
Return on equity is -174.4%, lower than 95% of its Medical Devices peers (median 3.5%)Significant
Return on equity: -1.74Industry median: 0.03Industry P5: -0.82Peers compared: 60.00
Current ratio is 30.79×, higher than 95% of its Medical Devices peers (median 2.86×)Significant
Current ratio: 30.79Industry median: 2.86Industry P95: 9.02Peers compared: 60.00
Financial Health
Consistent revenue growth patternNotable
Growth Consistency Score: 0.74
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Scale
Revenue is $5.04M, lower than 95% of all stocks globallySignificant
Revenue (USD): 5,037,918.763Global P5: 33,357,653.812
Market cap is $1.76B, above the global median of $1.18BNotable
Market cap (USD): 1,763,926,626.984Global Median: 1,180,223,658.953
Companies that share the same coordination system — how they create, deliver, or capture value.
Septarna Inc.
Tier 1ProductionApproval-Gated PipelineRule
Alivus Life Sciences Limited
Tier 1ProductionApproval-Gated PipelineRuleFlow
PolyPeptide Group AG
Tier 1ProductionApproval-Gated PipelineRuleFlow
Tibet Rhodiola Pharmaceutical Holding Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Novavax Inc.
Tier 1ProductionApproval-Gated PipelineRule
Jubilant Pharmova Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Inventisbio Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Nanobiotix S.A.
Tier 1ProductionApproval-Gated PipelineRule
Vir Biotechnology Inc.
Tier 1ProductionApproval-Gated PipelineRule
Hanall Biopharma Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule